{"id":667,"date":"2026-03-23T15:25:31","date_gmt":"2026-03-23T15:25:31","guid":{"rendered":"https:\/\/udqs.co.ke\/en\/?p=667"},"modified":"2026-04-01T13:56:31","modified_gmt":"2026-04-01T13:56:31","slug":"who-prequalification-a-strategic-roadmap-for-pharmaceutical-manufacturers-in-africa","status":"publish","type":"post","link":"https:\/\/udqs.co.ke\/en\/who-prequalification-a-strategic-roadmap-for-pharmaceutical-manufacturers-in-africa\/","title":{"rendered":"WHO Prequalification: A Strategic Roadmap for Pharmaceutical Manufacturers in Africa"},"content":{"rendered":"\n

As global demand for safe, high-quality medicines continues to grow, pharmaceutical manufacturers increasingly seek access to international procurement programs operated by organizations such as UNICEF, UNFPA, the Global Fund, and international development agencies<\/strong>.<\/p>\n\n\n\n

One of the most important pathways to entering these markets is through the World Health Organization (WHO) Prequalification Programme (PQ)<\/strong>.<\/p>\n\n\n\n

WHO Prequalification serves as a globally recognized quality assurance mechanism that evaluates whether medicines meet international standards for quality, safety, and efficacy<\/strong>. For pharmaceutical manufacturers across Africa, achieving WHO prequalification can open doors to significant procurement opportunities while strengthening their global credibility.<\/p>\n\n\n\n

Ultra Dynamic Quality Systems (UDQS) supports pharmaceutical organizations in preparing for WHO prequalification through structured regulatory strategies, GMP compliance programs, and technical documentation support.<\/p>\n\n\n\n

Understanding the WHO Prequalification Programme<\/strong><\/strong><\/p>\n\n\n\n

The WHO Prequalification Programme was established to ensure that medicines supplied through international procurement agencies meet internationally accepted quality standards.<\/p>\n\n\n\n

Under this programme, WHO evaluates pharmaceutical products based on several critical components, including:<\/p>\n\n\n\n

    \n
  1. Quality of the pharmaceutical product<\/li>\n\n\n\n
  2. Manufacturing facility compliance with GMP<\/li>\n\n\n\n
  3. Bioequivalence and clinical data<\/li>\n\n\n\n
  4. Stability and product performance<\/li>\n\n\n\n
  5. Regulatory documentation and dossiers<\/li>\n<\/ol>\n\n\n\n

    Products that successfully pass the evaluation are included in the WHO Prequalified List of Medicines<\/strong>, which procurement agencies rely upon when purchasing medicines for global health programs.<\/p>\n\n\n\n

    Why WHO Prequalification Matters<\/strong><\/strong><\/p>\n\n\n\n

    For pharmaceutical manufacturers, achieving WHO prequalification provides several strategic advantages.<\/p>\n\n\n\n

    Access to Global Procurement Marke<\/strong>t<\/p>\n\n\n\n

    Many international health programs procure medicines exclusively from manufacturers whose products are WHO prequalified.<\/p>\n\n\n\n

    These procurement programs represent billions of dollars in annual purchases of medicines for diseases such as:<\/p>\n\n\n\n

      \n
    1. HIV\/AIDS<\/li>\n\n\n\n
    2. Tuberculosis<\/li>\n\n\n\n
    3. Malaria<\/li>\n\n\n\n
    4. Maternal and reproductive health medicines<\/li>\n\n\n\n
    5. Vaccines and biologics<\/li>\n<\/ol>\n\n\n\n

      Manufacturers that achieve WHO prequalification gain access to these important markets.<\/p>\n\n\n\n

      Strengthened Regulatory Credibility<\/strong><\/strong><\/p>\n\n\n\n

      WHO prequalification is widely recognized as a mark of quality and regulatory excellence.<\/p>\n\n\n\n

      Manufacturers with prequalified products often find it easier to obtain approvals from national regulatory authorities in multiple countries.<\/p>\n\n\n\n

      This recognition can significantly accelerate market expansion.<\/p>\n\n\n\n

      Improved Quality Systems<\/strong><\/strong><\/p>\n\n\n\n

      The process of preparing for WHO prequalification requires organizations to strengthen their quality systems, manufacturing processes, and regulatory documentation<\/strong>.<\/p>\n\n\n\n

      As a result, companies often emerge from the process with stronger operational systems and improved production reliability.<\/p>\n\n\n\n

      Key Requirements for WHO Prequalification<\/strong><\/strong><\/p>\n\n\n\n

      Manufacturers seeking WHO prequalification must satisfy several critical requirements.<\/p>\n\n\n\n

      GMP-Compliant Manufacturing Facilities<\/strong><\/strong><\/p>\n\n\n\n

      Manufacturing facilities must comply with WHO GMP guidelines<\/strong> and undergo inspection by WHO assessors.<\/p>\n\n\n\n

      These inspections evaluate:<\/p>\n\n\n\n

        \n
      1. Facility design and cleanliness<\/li>\n\n\n\n
      2. Production processes<\/li>\n\n\n\n
      3. Quality control laboratories<\/li>\n\n\n\n
      4. Documentation systems<\/li>\n\n\n\n
      5. Personnel training<\/li>\n\n\n\n
      6. Data integrity practices<\/li>\n<\/ol>\n\n\n\n

        Facilities must demonstrate consistent compliance with international GMP standards.<\/p>\n\n\n\n

        Product Dossier Submission<\/strong><\/strong><\/p>\n\n\n\n

        Manufacturers must submit a comprehensive product dossier<\/strong> describing the pharmaceutical product in detail.<\/p>\n\n\n\n

        This dossier typically includes:<\/p>\n\n\n\n

          \n
        1. Product formulation<\/li>\n\n\n\n
        2. Manufacturing processes<\/li>\n\n\n\n
        3. Analytical methods<\/li>\n\n\n\n
        4. Stability studies<\/li>\n\n\n\n
        5. Bioequivalence data<\/li>\n\n\n\n
        6. Packaging and labeling information<\/li>\n<\/ol>\n\n\n\n

          The dossier is reviewed by WHO experts to ensure the product meets international quality standards.<\/p>\n\n\n\n

          Bioequivalence Studies<\/strong><\/strong><\/p>\n\n\n\n

          For generic pharmaceutical products, manufacturers must demonstrate that their product is bioequivalent to the reference product<\/strong>.<\/p>\n\n\n\n

          Bioequivalence studies confirm that the generic medicine performs in the body in the same way as the original product.<\/p>\n\n\n\n

          Ongoing Compliance and Monitoring<\/strong><\/strong><\/p>\n\n\n\n

          Even after achieving prequalification, manufacturers must maintain compliance with WHO standards.<\/p>\n\n\n\n

          WHO conducts periodic inspections and monitors product performance to ensure that quality standards continue to be met.<\/p>\n\n\n\n

          Challenges Faced by Emerging Manufacturers<\/strong><\/strong><\/p>\n\n\n\n

          Pharmaceutical manufacturers in emerging markets often face challenges when pursuing WHO prequalification.<\/p>\n\n\n\n

          Common challenges include:<\/p>\n\n\n\n

            \n
          1. Incomplete GMP systems<\/li>\n\n\n\n
          2. Limited regulatory documentation experience<\/li>\n\n\n\n
          3. Insufficient validation data<\/li>\n\n\n\n
          4. Weak data integrity controls<\/li>\n\n\n\n
          5. Inadequate stability studies<\/li>\n<\/ol>\n\n\n\n

            Addressing these challenges requires careful planning and technical expertise.<\/p>\n\n\n\n

            The UDQS Approach to WHO Prequalification<\/strong><\/strong><\/p>\n\n\n\n

            Ultra Dynamic Quality Systems (UDQS) assists pharmaceutical manufacturers through every stage of the prequalification process.<\/p>\n\n\n\n

            Key support services include:<\/p>\n\n\n\n

              \n
            1. GMP gap assessments against WHO standards<\/li>\n\n\n\n
            2. Development and strengthening of Quality Management Systems<\/li>\n\n\n\n
            3. Validation and qualification programs<\/li>\n\n\n\n
            4. Regulatory dossier preparation<\/li>\n\n\n\n
            5. Data integrity system implementation<\/li>\n\n\n\n
            6. Inspection readiness preparation<\/li>\n<\/ol>\n\n\n\n

              By combining regulatory knowledge with practical operational experience, UDQS helps organizations navigate the complex pathway toward WHO prequalification.<\/p>\n\n\n\n

              Strengthening Pharmaceutical Manufacturing in Africa<\/strong><\/strong><\/p>\n\n\n\n

              As African countries invest in expanding local pharmaceutical production, achieving internationally recognized quality standards becomes increasingly important.<\/p>\n\n\n\n

              WHO prequalification provides a clear pathway for manufacturers to demonstrate compliance with global regulatory expectations while gaining access to international procurement markets.<\/p>\n\n\n\n

              Organizglobal healthcare supply chain.<\/p>\n\n\n\n

              Start Your WHO Prequalification Journey<\/strong><\/strong><\/p>\n\n\n\n

              Ultra Dynamic Quality Systems (UDQS) supports pharmaceutical manufacturers across Africa in building the technical and regulatory foundations required for WHO prequalification.<\/p>\n\n\n\n

              ations that successfully achieve prequalification position themselves as trusted partners in the<\/p>\n\n\n\n

              Whether your organization is strengthening its GMP systems, preparing regulatory dossiers, or planning new pharmaceutical products, UDQS can provide the expertise needed to successfully navigate the prequalification process.<\/p>\n\n

              \n\n\t\t\n
                \n\t\t\t <\/ul>\n <\/div> \n","protected":false},"excerpt":{"rendered":"

                One of the most important pathways to entering these markets is through the World Health Organization (WHO) Prequalification Programme (PQ).<\/p>\n","protected":false},"author":2,"featured_media":864,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"postBodyCss":"","postBodyMargin":[],"postBodyPadding":[],"postBodyBackground":{"backgroundType":"classic","gradient":""},"footnotes":""},"categories":[11],"tags":[20,19],"class_list":["post-667","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-udqs-newsroom","tag-strengthened-regulatory-credibility","tag-understanding-the-who-prequalification-programme"],"_links":{"self":[{"href":"https:\/\/udqs.co.ke\/en\/wp-json\/wp\/v2\/posts\/667","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/udqs.co.ke\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/udqs.co.ke\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/udqs.co.ke\/en\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/udqs.co.ke\/en\/wp-json\/wp\/v2\/comments?post=667"}],"version-history":[{"count":3,"href":"https:\/\/udqs.co.ke\/en\/wp-json\/wp\/v2\/posts\/667\/revisions"}],"predecessor-version":[{"id":865,"href":"https:\/\/udqs.co.ke\/en\/wp-json\/wp\/v2\/posts\/667\/revisions\/865"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/udqs.co.ke\/en\/wp-json\/wp\/v2\/media\/864"}],"wp:attachment":[{"href":"https:\/\/udqs.co.ke\/en\/wp-json\/wp\/v2\/media?parent=667"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/udqs.co.ke\/en\/wp-json\/wp\/v2\/categories?post=667"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/udqs.co.ke\/en\/wp-json\/wp\/v2\/tags?post=667"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}